Liver Metastasis Completed Phase 2 Trials for Bevacizumab (DB00112)

IndicationStatusPhase
DBCOND0029622 (Liver Metastasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01632722Perioperative vs Postoperative Chemotherapy + Bevacizumab in Colorectal Cancer, Liver MetsTreatment